GHRP-2

Growth Hormone
Chemical Profile
Molecular Formula
C45H55N9O6
Molar Mass
818.0 g/mol
CAS Number
158861-67-7
Purity Standard
99%+ (HPLC Verified)
Amino Acid Sequence
D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2

Overview

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide growth hormone secretagogue with one of the highest GH-releasing potencies in its class. The incorporation of D-2-naphthylalanine in place of D-tryptophan (as in GHRP-6) provides enhanced receptor binding and a somewhat improved selectivity profile.

Research demonstrates GHRP-2 produces substantial GH release while causing less appetite stimulation than GHRP-6, though still more than highly selective compounds like ipamorelin. It does stimulate modest cortisol, prolactin, and ACTH release, indicating activation of multiple hypothalamic-pituitary pathways.

The compound's high potency makes it valuable for research requiring maximal GH stimulation, such as pituitary reserve testing or studies of GH-deficient states. Its robust GH response in aged subjects has made it a useful tool in somatopause research.

GHRP-2 represents an important step in the evolution of GH secretagogues, bridging the gap between first-generation compounds like GHRP-6 and the highly selective agents developed subsequently. Its intermediate selectivity profile provides researchers with options for balancing GH potency against hormonal side effects.

Synthesis Overview

GHRP-2 is synthesized via Fmoc solid-phase peptide synthesis incorporating D-alanine, D-2-naphthylalanine (D-2-Nal), and D-phenylalanine as non-natural amino acids. The D-2-Nal residue requires specialized coupling protocols due to steric considerations. Following synthesis and cleavage, purification is achieved via preparative HPLC with careful separation from D/L epimer impurities. Final characterization includes mass spectrometry, HPLC purity, and chiral analysis.

Research Applications

  • High-potency GH secretagogue receptor activation studies
  • Comparative GH release analysis with GHRP-6 and ipamorelin
  • ACTH and cortisol co-stimulation research
  • Pituitary reserve and GH secretory capacity assessment
  • Aging-related GH decline intervention studies
  • GHS-R1a receptor binding and signal transduction analysis

Related Compounds